Signaling Pathway
Spevatamig is a bispecific antibody of the (H-??1_L-??)_(H-??1_L-??) type, designed to target CD47 and CLDN18. This dual specificity facilitates its application in the selective targeting and inhibition of pathways crucial in cancer cell survival and immune evasion, making it a valuable tool for research in oncology and immunotherapy.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Spevatamig is a bispecific antibody of the (H-??1_L-??)_(H-??1_L-??) type, designed to target CD47 and CLDN18. This dual specificity facilitates its application in the selective targeting and inhibition of pathways crucial in cancer cell survival and immune evasion, making it a valuable tool for research in oncology and immunotherapy. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
